Washington Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$573K	Buy	10,150 +5,850	+136%	+$341K	0.48%	72
2025 Q4	$256K	Buy	+4,300	New	+$234K	0.21%	96
2024 Q3	–	Sell	-6,500	Closed	-$535K	–	112
2024 Q2	$535K	Hold	6,500	–	–	0.45%	69
2024 Q1	$568K	Hold	6,500	–	–	0.46%	71
2023 Q4	$627K	Hold	6,500	–	–	0.54%	53
2023 Q3	$575K	Hold	6,500	–	–	0.53%	51
2023 Q2	$563K	Hold	6,500	–	–	0.48%	61
2023 Q1	$632K	Hold	6,500	–	–	0.56%	42
2022 Q4	$673K	Sell	6,500 -1,700	-21%	-$160K	0.62%	42
2022 Q3	$695K	Hold	8,200	–	–	0.7%	38
2022 Q2	$680K	Hold	8,200	–	–	0.65%	40
2022 Q1	$632K	Hold	8,200	–	–	0.52%	53
2021 Q4	$724K	Hold	8,200	–	–	0.59%	47
2021 Q3	$634K	Hold	8,200	–	–	0.56%	44
2021 Q2	$684K	Hold	8,200	–	–	0.83%	38
2021 Q1	$619K	Hold	8,200	–	–	0.58%	56
2020 Q4	$719K	Hold	8,200	–	–	0.69%	39
2020 Q3	$624K	Buy	8,200 +1,700	+26%	+$172K	0.64%	45
2020 Q2	$802K	Hold	6,500	–	–	0.89%	28
2020 Q1	$549K	Hold	6,500	–	–	0.69%	42
2019 Q4	$550K	Buy	6,500 +2,900	+81%	+$219K	0.47%	52
2019 Q3	$243K	Hold	3,600	–	–	0.24%	92
2019 Q2	$308K	Buy	+3,600	New	+$308K	0.35%	85